OKX 的作风给我感觉就是有点太专注技术和产品了，导致有时候和资产端有点脱离。我在很长一段时间内都并未意识到，以 Hyperliquid 为代表的一类 perpdex 更像是利用监管漏洞进行监管套利的 CEX，和以往的 GMX 等产品有着比较大的差异但同时也是优越性。现在不可否认的是这轮 perpdex 的资产炒作热很成功，市场对这一类新叙事有着明显偏好而 Star @star_okx 的核心观点很显然，是认为未来有可能这部分也会被纳入监管。但这并不妨碍在未纳入监管的红利期中，perpdex 能够捕获非常大一块无 KYC 用户和无需合规监管的资产自 BN Alpha 上线后，除币安之外的交易所不同程度遇到了交易量和上币费用等问题的挤压。或许未来每个 CEX 都会有自己的 perpdex 来卷这一大块无 KYC 用户从吸引用户的手法来说：一个有代币激励的高控筹模型能够产生非常大的补贴激励——吸引用户使用交手续费——手续费回购代币形成现货买压。这看来是一套行之有效的飞轮模型，现如今 $OKB 也已 CEX 主体进行了拆分，如果以 $OKB 为基础或者是自拉一个 perpdex 代币，都是可能的补贴飞轮解决方案，很 ...

Core Insights - The adoption of silicon carbide (SiC) power modules is transitioning from a high-performance option to a core hardware driving the energy revolution, evidenced by Tesla's Model 3 and BYD's cost reductions [2][4] - SiC's superior physical properties enable its application across various sectors, including electric vehicles, photovoltaic energy storage, and industrial motors, leading to a more efficient and reliable electronic power system [2][4] - The industry is on the brink of explosive growth, shifting focus from usability to cost-effectiveness and stability, with China leveraging its large renewable energy market and strong policy support [2][4] Group 1: Efficiency Revolution - SiC is redefining power electronics through its wide bandgap and superior thermal and electrical properties, allowing for higher efficiency and performance in applications like photovoltaic inverters [4][5] - SiC devices can operate at temperatures above 200°C and have a breakdown field strength ten times that of silicon, significantly enhancing system performance [4][5] Group 2: Multi-Scene Empowerment - SiC's influence extends beyond electric vehicles to include photovoltaic systems, energy storage, and AI data centers, showcasing its versatility and efficiency improvements [6][7] - In the electric vehicle sector, SiC MOSFETs can enhance driving range by approximately 5% and enable rapid charging capabilities [6][7] Group 3: Flywheel Model - The development of the SiC industry follows a flywheel model where technological advancements lead to cost reductions, which in turn promote application penetration and scale demand [9][10] - The transition from 6-inch to 12-inch wafers is a key driver for reducing manufacturing costs by 30-40%, facilitating broader market adoption [9][10] Group 4: Multi-Polar Application Demand - The growth of the SiC market is driven by diverse applications, including electric vehicles, photovoltaic energy systems, and industrial energy upgrades, creating a synergistic effect that accelerates technology iteration and cost reduction [21][22] - The penetration of SiC in electric vehicles is expected to reach 20% by 2025, with significant adoption across various vehicle models [22][24] Group 5: Global Landscape and Competitive Dynamics - The global SiC market is dominated by US, European, and Japanese companies, with significant market shares and competitive strategies focused on technology patents and price competition [34][35] - Chinese companies are rapidly advancing in the SiC industry, achieving notable progress in substrate materials and module packaging, although challenges remain in high-end chip design and manufacturing [37][38] Group 6: Future Outlook and Investment Strategies - The SiC industry is expected to continue its rapid growth, with a focus on technological breakthroughs, cost control, and ecosystem collaboration as key competitive factors [54][55] - Investment strategies should prioritize companies with established competitive advantages, strong customer relationships, and the ability to scale production effectively [51][52]

Financial Data and Key Metrics Changes - The total revenue for the first half of 2025 reached RMB87.3 billion, slightly down from the same period last year, with overseas revenue increasing from 43% to 53% of total revenue [3][4] - Industrial operating profit remained stable at RMB3.15 billion, with profit attributable to the owner of the parent at RMB0.66 billion [3] - Adjusted NAV reached HKD18 per share, reflecting continuous improvement [4] - Cash and cash equivalents reached RMB67.83 billion, with a decrease in the average cost of borrowing from 5.6% to 5.3% [5][6] Business Line Data and Key Metrics Changes - The Health segment recorded RMB22.57 billion in total revenues, with net profit to parents increasing by 48.3% year on year [22] - Fosun Pharma's revenue was RMB19.43 billion, with innovative drug revenue rising by 14% year on year [25][26] - The Wealth segment's total revenue was RMB27.83 billion, up by 3.3% year on year, primarily driven by growth in insurance revenue [39] - The Intelligent Manufacturing segment recorded RMB4 billion in revenue, a decrease of 24.6% year on year, primarily due to the consolidation scope [42] Market Data and Key Metrics Changes - Overseas revenue for Fosun Pharma accounted for 38.1% of total revenue, with a year-on-year increase of 2.1 bps [23] - The tourism business, particularly Club Med, reported a record high revenue during the reporting period, operating in 40 countries and regions [34][51] - Yiren's jewelry and fashion segment showed signs of recovery in Q2, with revenue rebounding to RMB7.61 billion [35] Company Strategy and Development Direction - The company aims to create a global happiness ecosystem focusing on health, happiness, and wealth [46] - Strategic focus includes business streamlining, transitioning to asset-light operations, and enhancing technological innovation [48][49] - The company is committed to globalization, with overseas revenue accounting for 53% of total revenue [49] - The flywheel model is being implemented, connecting insurance capital with investment and industrial operations [52] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the recovery of the consumption sector and the potential for innovative drugs [64] - The company is focusing on existing sectors where it has established strengths rather than entering new sectors [68] - There is a strong emphasis on technological advancements, particularly in AI and gene development, to drive future innovation [67] Other Important Information - The company has been recognized for its strong ESG performance, aiming for peak carbon emissions by 2028 and carbon neutrality by 2050 [58][60] - Significant investments have been made in R&D, with Fosun Pharma's expenditures reaching RMB2.58 billion [24] Q&A Session Summary Question: What sectors will the company focus on in the second half? - Management highlighted confidence in the recovery of the consumption sector and breakthroughs in innovative drugs, emphasizing potential in their pipeline [64] Question: How does the company view its innovation strategy? - The company aims to build its own global R&D capabilities and is focused on licensing in and out, with a long-term vision to become a major player in the pharmaceutical market [66] Question: What is the company's approach to new sectors? - Management stated that the focus will remain on sectors where the company has established strengths, rather than pursuing new sectors without a solid foundation [68]